# The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers

> **NCT01482117** · NA · COMPLETED · sponsor: **Inje University** · enrollment: 28 (actual)

## Conditions studied

- Interaction

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Cilostazol
- **DRUG:** Clopidogrel/Cilostazol

## Key facts

- **NCT ID:** NCT01482117
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-01
- **Final completion:** 2012-02
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2013-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01482117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01482117, "The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01482117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*